Clinical Trial Update: Observational Study of Low Dose FCR in Elderly/Comorbid CLL/SLL: The Q-lite Project

View source ↗

Summary

Observational study (the Q-lite Project) evaluating low-dose fludarabine-cyclophosphamide-rituximab (FCR) in elderly or comorbid patients with chronic lymphocyt…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Fludarabine (Fludarabine)
• Rituximab (rituximab)

Snippet

Sponsor: Czech CLL Study Group | Conditions: Chronic Lymphocytic Leukemia | Status: UNKNOWN